Search research articles
Contact Us
Filters
Showing results (191-200 of 198) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 198 results.
Immunity
|
March 1, 1997
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
M Romano, M Sironi, C Toniatti, et al.
Pharmacological Research
|
May 29, 1998
Within-patient variability of hormone and cytokine concentrations in heart failure
S Masson, R Latini, M Bevilacqua, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2001
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
A L Sirén, M Fratelli, M Brines, et al.
European Journal of Pharmacology
|
December 19, 1996
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in mice
P Ghezzi, S Garattini, T Mennini, et al.
Circulation
|
August 10, 2000
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans
G Peri, M Introna, D Corradi, et al.
The Journal of Experimental Medicine
|
June 8, 1999
Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells
R Bertini, O M Howard, H F Dong, et al.
Journal of the American Society of Nephrology : JASN
|
March 30, 2023
Is There More than One Erythropoietin Receptor? Can the Hematopoietic Effects of EPO Be Dissociated from the Organ-Protective Effects by Carbamylated Erythropoietin?: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242, 2004
M Leist, P Ghezzi, G Grasso, et al.
Redox Biology
|
November 7, 2017
Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162]
J Egea, I Fabregat, Y M Frapart, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 198) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 198 results.
Immunity
|
March 1, 1997
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
M Romano, M Sironi, C Toniatti, et al.
Pharmacological Research
|
May 29, 1998
Within-patient variability of hormone and cytokine concentrations in heart failure
S Masson, R Latini, M Bevilacqua, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2001
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
A L Sirén, M Fratelli, M Brines, et al.
European Journal of Pharmacology
|
December 19, 1996
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in mice
P Ghezzi, S Garattini, T Mennini, et al.
Circulation
|
August 10, 2000
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans
G Peri, M Introna, D Corradi, et al.
The Journal of Experimental Medicine
|
June 8, 1999
Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells
R Bertini, O M Howard, H F Dong, et al.
Journal of the American Society of Nephrology : JASN
|
March 30, 2023
Is There More than One Erythropoietin Receptor? Can the Hematopoietic Effects of EPO Be Dissociated from the Organ-Protective Effects by Carbamylated Erythropoietin?: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242, 2004
M Leist, P Ghezzi, G Grasso, et al.
Redox Biology
|
November 7, 2017
Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162]
J Egea, I Fabregat, Y M Frapart, et al.
Page
of 20